Lickliter JD - Search Results

1

First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjects.

Yang J, Lickliter JD, Hillson JL, Means GD, Sanderson RJ, Carley K, Tercero A, Manjarrez KL, Wiley JR, Peng SL. Yang J, et al. Among authors: lickliter jd. Clin Transl Sci. 2021 Jul;14(4):1314-1326. doi: 10.1111/cts.12983. Epub 2021 Mar 2. Clin Transl Sci. 2021. PMID: 33503289 Free PMC article. Clinical Trial.

2

Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers.

Schluep T, Lickliter J, Hamilton J, Lewis DL, Lai CL, Lau JY, Locarnini SA, Gish RG, Given BD. Schluep T, et al. Clin Pharmacol Drug Dev. 2017 Jul;6(4):350-362. doi: 10.1002/cpdd.318. Epub 2016 Dec 12. Clin Pharmacol Drug Dev. 2017. PMID: 27739230 Free PMC article. Clinical Trial.

3

Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects.

Tang KY, Lickliter J, Huang ZH, Xian ZS, Chen HY, Huang C, Xiao C, Wang YP, Tan Y, Xu LF, Huang YL, Yan XQ. Tang KY, et al. Cell Mol Immunol. 2019 May;16(5):473-482. doi: 10.1038/s41423-018-0029-8. Epub 2018 Apr 18. Cell Mol Immunol. 2019. PMID: 29670279 Free PMC article. Clinical Trial.

4

STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD^® ) Device, in Healthy Adult Subjects.

Shrewsbury SB, Jeleva M, Satterly KH, Lickliter J, Hoekman J. Shrewsbury SB, et al. Headache. 2019 Mar;59(3):394-409. doi: 10.1111/head.13476. Epub 2019 Jan 19. Headache. 2019. PMID: 30659611 Clinical Trial.

5

First-in-Human Pharmacokinetics and Safety Study of GSK3008356, a Selective DGAT1 Inhibitor, in Healthy Volunteers.

Okour M, Gress A, Zhu X, Rieman D, Lickliter JD, Brigandi RA. Okour M, et al. Among authors: lickliter jd. Clin Pharmacol Drug Dev. 2019 Nov;8(8):1088-1099. doi: 10.1002/cpdd.691. Epub 2019 Apr 5. Clin Pharmacol Drug Dev. 2019. PMID: 30950565 Clinical Trial.

6

Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects.

Lickliter JD, Lawrence K, O'Donnell J, Isaacs R. Lickliter JD, et al. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00071-20. doi: 10.1128/AAC.00071-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32284380 Free PMC article. Clinical Trial.

7

The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults.

Shrewsbury SB, Hocevar-Trnka J, Satterly KH, Craig KL, Lickliter JD, Hoekman J. Shrewsbury SB, et al. Among authors: lickliter jd. J Clin Psychiatry. 2020 Jun 30;81(4):19m13086. doi: 10.4088/JCP.19m13086. J Clin Psychiatry. 2020. PMID: 32609960 Free article. Clinical Trial.

8

A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers.

Hosseini A, McLachlan AJ, Lickliter JD. Hosseini A, et al. Among authors: lickliter jd. Br J Clin Pharmacol. 2021 Apr;87(4):2070-2077. doi: 10.1111/bcp.14617. Epub 2020 Nov 18. Br J Clin Pharmacol. 2021. PMID: 33075170 Free article. Clinical Trial.

9

A randomized, double-blind, parallel-group, single-dose comparative pharmacokinetic study of DRL_TZ, a candidate biosimilar of trastuzumab, with Herceptin^® (EU) in healthy adult males.

Lickliter JD, Dadhania RN, Trivedi RK, Naveen Kumar SR, Reddy PK. Lickliter JD, et al. Indian J Med Res. 2021 Mar;154(3):509-519. doi: 10.4103/ijmr.IJMR_1119_18. Indian J Med Res. 2021. PMID: 35142643 Free PMC article. Clinical Trial.

10

A phase I randomized, double-blinded, placebo-controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects.

Lickliter J, Wang S, Zhang W, Zhu H, Wang J, Zhao C, Shen H, Wang Y. Lickliter J, et al. Clin Transl Sci. 2023 Sep;16(9):1691-1703. doi: 10.1111/cts.13580. Epub 2023 Jul 4. Clin Transl Sci. 2023. PMID: 37345561 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page